Skip to main content
Nxera Pharma Co., Ltd. logo

Nxera Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4565 ISIN · JP3431300007 LEI · 2138004M62BFNJMR2Z82 T Manufacturing
Open in API
Filings indexed 113 across all filing types
Latest filing 2023-05-12 Report Publication Anno…
Country JP Japan
Listing T 4565

About Nxera Pharma Co., Ltd.

https://www.nxera.life/

Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically accompanying a Quarterly Report (Dai-ichi shihanki hokokusho). It confirms the accuracy of the quarterly report for the period ending March 31, 2023. Since this is a regulatory filing required by the Kanto Local Finance Bureau and does not constitute the full financial report itself, but rather a formal regulatory confirmation document, it falls under the RNS category.
2023-05-12 Japanese
四半期報告書－第34期第1四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, management analysis (MDA), and operational updates, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report (RPA) as it contains the full substantive financial data. Q1 2023
2023-05-12 Japanese
内部統制報告書－第33期(2022/01/01－2022/12/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. This type of report is a mandatory regulatory filing that assesses the effectiveness of a company's internal controls over financial reporting. Since it does not fit into specific categories like 10-K (Annual Report), ER (Earnings Release), or others, and is a formal regulatory submission, it is best classified as a Regulatory Filing (RNS).
2023-03-23 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, specifically related to the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). While it references the Annual Report, it is a standalone regulatory filing confirming the validity of the report's contents by the CEO and CFO. Since it is a regulatory filing that does not fit into the specific categories of a full report or a simple announcement, it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-23 Japanese
有価証券報告書－第33期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, management indicators, and corporate history for the fiscal year ending December 31, 2022. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau. FY 2022
2023-03-23 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically accompanying a Quarterly Report (第３四半期報告書). While it references a quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the financial statements by the CEO and CFO. Since it is a specific regulatory requirement for filing financial reports in Japan and does not contain the full financial data itself, it falls under the general regulatory filing category.
2022-11-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.